UL Proposes Best Practices For Personal-Care Safety Assessments

The cosmetics industry could benefit from concrete standards for conducting product and ingredient risk assessments, UL suggests in a white paper recommending best practices based on safety-review frameworks used by the European Commission's Scientific Committee on Consumer Safety, Cosmetic Ingredient Review, the Research Institute for Fragrance Materials and others. The certification and consulting firm's research revealed variability in firms' approaches to risk assessment, it says.

Standardization of personal-care risk assessment according to best practices could help to alleviate consumer concerns about cosmetic ingredients, according to global safety consulting and certification firm UL, which is jockeying for an intermediary role between industry and an increasingly safety-conscious public.

"UL believes there is a role for third parties to bridge the confidence gap and provide an effective means to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

People In US Consumer Health News: Bayer North America Treasurer Takes On CFO Role, Too

 

Bayer North America CFO with firm since 2008; Cosette VP for quality, regulatory affairs; FDA labeling review official joins ProPharma; Lifecykel, UFC veterans launch Mongolian training camp; and Beverly Hills surgeons offer skin care supplement.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By 

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

Remote Regulatory Assessments Become Swiss Army Knife For US FDA’s Oversight Of Facilities

 

“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.